The All India Medical Institute of Medical Sciences (AIIMS), Delhi, began screening of children for the trial of Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started on Monday. The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for … Continue reading AIIMS Delhi begins screening of children for Covaxin trial